AI-driven drug discovery and synthesis

Targeting prion disease reversal using CRISPR-based epigenetic reprogramming

prion disease CRISPR epigenetic reprogramming neurodegenerative disorders protein misfolding

Measuring axonal propagation delays in neurodegenerative diseases using ultrafast imaging

axonal propagation neurodegeneration ultrafast imaging biomarkers neural signaling

**Through inflammasome inhibition: Novel approaches to combat chronic neurodegenerative diseases**

neuroinflammation NLRP3 inhibitors neurodegenerative therapies cytokine modulation blood-brain barrier

Accelerating automated retrosynthesis with neurosymbolic integration techniques

retrosynthesis neurosymbolic AI chemical synthesis route planning machine learning

Advancing continuous flow chemistry with AI-optimized reaction pathways for pharmaceutical synthesis

flow chemistry AI optimization drug synthesis microreactors reaction prediction

Accelerating antiviral drug discovery using reaction prediction transformers for pandemic preparedness

reaction prediction transformers antiviral drugs pandemic response AI drug discovery computational chemistry

Developing senolytic drugs targeting mitochondrial dysfunction for age-related disease treatment

senolytics mitochondrial dysfunction aging age-related diseases drug discovery

Accelerating drug discovery using computational retrosynthesis with transformer-based models

computational retrosynthesis drug discovery transformer models synthetic pathways pharmaceuticals

Optimizing automated retrosynthesis pathways using quantum computing algorithms

quantum computing retrosynthesis organic chemistry algorithm optimization molecular design

Through proteostasis network modulation to reverse age-related protein aggregation in neurons

proteostasis neurodegeneration aging protein aggregation drug discovery

Decoding protein folding intermediates with machine learning-enhanced cryo-EM techniques

protein folding cryo-electron microscopy machine learning structural biology intermediate states

For senolytic drug discovery during circadian rhythm minima

senolytics circadian biology aging therapeutics drug timing cellular senescence